Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV multicenter single-arm study of lobaplatin-containing chemotherapy for small cell lung cancer
ChiCTR-ONC-13003471Phase 4Recruiting
- Sponsor
- Jilin Provincial Cancer Hospital
- Start
- Aug 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lobaplatin in small cell lung cancer (SCLC), sponsored by Jilin Provincial Cancer Hospital. Primary endpoint: Safety. Started Aug 2013; status: recruiting.
02
Drugs
lobaplatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on ChiCTR-ONC-13003471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003471.